Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The pharmacokinetics of glimepiride and metformin HCl will be compared after single dose
intake of both combinations in order to answer the following questions:
- Is Amaryl-M 1/500 mg (Test tablet) proportional to Amaryl-M 2/500 mg tablet with regard
to the glimepiride component?
- Is Amaryl-M 1/500 mg (Test tablet) tolerable comparing with Amaryl-M 2/500 mg?